Covalent PPARgamma inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARgamma/RXRalpha-activated urothelial carcinoma. (linkinghub.elsevier.com)

Authors: Stuckey JI … Sims RJ 3rd Journal: Cell Chemical Biology Published: 2026-06-18 DOI: https://doi.org/10.1016/j.chembiol.2026.04.017